Medicinal products for the treatment of insomnia

Current effective version

PDF iconRevision 1 - Adopted guideline

Reference numberCHMP/16274/2009 Rev. 1
Effective from01/09/2011
KeywordsInsomnia, primary insomnia, secondary insomnia, diagnostic criteria, co-morbidity, special populations, polysomnography, treatment options, short-term efficacy, long-term maintenance
DescriptionThis document provides guidance on the development of medicinal products for acute and long-term treatment of insomnia. It focuses mailny on primary insomnia, but covers alco some issues on secondary or co-morbid insomnia.

Document history

Revision 1

Current version

PDF iconAdopted guideline

PDF iconOverview of comments

PDF iconDraft guideline

PDF iconConcept paper

In operation: 01/09/2011–present

Published: 02/03/2011

Published: 11/11/2009

Published: 19/07/2007

First versionAdopted guidelineIn operation: 01/03/1993–31/08/2011

Related content

How useful was this page?

Add your rating